Cargando…

Carbidopa-Based Modulation of the Functional Effect of the AAV2-hAADC Gene Therapy in 6-OHDA Lesioned Rats

Progressively blunted response to L-DOPA in Parkinson’s disease (PD) is a critical factor that complicates long-term pharmacotherapy in view of the central importance of this drug in management of the PD-related motor disturbance. This phenomenon is likely due to progressive loss of one of the key e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciesielska, Agnieszka, Sharma, Nitasha, Beyer, Janine, Forsayeth, John, Bankiewicz, Krystof
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4393141/ https://www.ncbi.nlm.nih.gov/pubmed/25860990 http://dx.doi.org/10.1371/journal.pone.0122708

Ejemplares similares

Safety and tolerability of MRI-guided infusion of AAV2-hAADC into the mid-brain of nonhuman primate
por: Sebastian, Waldy San, et al.
Publicado: (2014)

Depletion of AADC activity in caudate nucleus and putamen of Parkinson’s disease patients; implications for ongoing AAV2-AADC gene therapy trial
por: Ciesielska, Agnieszka, et al.
Publicado: (2017)

Evaluation of an AAV2-Based Rapamycin-Regulated Glial Cell Line-Derived Neurotrophic Factor (GDNF) Expression Vector System
por: Hadaczek, Piotr, et al.
Publicado: (2011)

Widespread AAV1- and AAV2-mediated transgene expression in the nonhuman primate brain: implications for Huntington’s disease
por: Hadaczek, Piotr, et al.
Publicado: (2016)

Axonal transport of AAV9 in nonhuman primate brain
por: Green, Foad, et al.
Publicado: (2016)

Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons
por: Pearson, Toni S., et al.
Publicado: (2021)

Magnetic resonance imaging–guided phase 1 trial of putaminal AADC gene therapy for Parkinson's disease
por: Christine, Chadwick W., et al.
Publicado: (2019)

Axonal transport of adeno-associated viral vectors is serotype-dependent
por: Salegio, Ernesto A., et al.
Publicado: (2012)

Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial
por: Christine, Chadwick W., et al.
Publicado: (2022)

Compound Heterozygosis in AADC Deficiency and Its Complex Phenotype in Terms of AADC Protein Population
por: Bisello, Giovanni, et al.
Publicado: (2022)

Convection-Enhanced Delivery of AAV2-PrPshRNA in Prion-Infected Mice
por: Ahn, Misol, et al.
Publicado: (2014)

Kinetics and MR-Based Monitoring of AAV9 Vector Delivery into Cerebrospinal Fluid of Nonhuman Primates
por: Ohno, Kousaku, et al.
Publicado: (2018)

ADENO-ASSOCIATED VIRUS TYPE 6 IS RETROGRADELY TRANSPORTED IN THE NON-HUMAN PRIMATE BRAIN
por: Sebastian, Waldy San, et al.
Publicado: (2013)

Role of Endothelial AADC in Cardiac Synthesis of Serotonin and Nitrates Accumulation
por: Rouzaud-Laborde, Charlotte, et al.
Publicado: (2012)

Gene therapy in the putamen for curing AADC deficiency and Parkinson's disease
por: Hwu, Paul Wuh‐Liang, et al.
Publicado: (2021)

Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency
por: Tai, Chun-Hwei, et al.
Publicado: (2022)

MR-Guided Delivery of AAV2-BDNF into the Entorhinal Cortex of Non-Human Primates
por: Nagahara, Alan H., et al.
Publicado: (2018)

Blood, urine and cerebrospinal fluid analysis in TH and AADC deficiency and the effect of treatment
por: Wassenberg, Tessa, et al.
Publicado: (2021)

Convection-enhanced delivery improves distribution and efficacy of tumor-selective retroviral replicating vectors (RRV) in a rodent brain tumor model
por: Yin, Dali, et al.
Publicado: (2013)

The Use of Convection-Enhanced Delivery with Liposomal Toxins in Neurooncology
por: Fiandaca, Massimo S., et al.
Publicado: (2011)

Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa
por: Othman, Ahmed A., et al.
Publicado: (2017)

Aromatic L-Amino Acid Decarboxylase (AADC) Is Crucial for Brain Development and Motor Functions
por: Shih, De-Fen, et al.
Publicado: (2013)

Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency
por: Wassenberg, Tessa, et al.
Publicado: (2017)

Comparison of the pharmacokinetics of an oral extended‐release capsule formulation of carbidopa‐levodopa (IPX066) with immediate‐release carbidopa‐levodopa (Sinemet(®)), sustained‐release carbidopa‐levodopa (Sinemet(®) CR), and carbidopa‐levodopa‐entacapone (Stalevo(®))
por: Hsu, Ann, et al.
Publicado: (2015)

Distribution of nanoparticles throughout the cerebral cortex of rodents and non-human primates: Implications for gene and drug therapy
por: Salegio, Ernesto A., et al.
Publicado: (2014)

Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications
por: Fiandaca, Massimo S., et al.
Publicado: (2012)

AADC deficiency from infancy to adulthood: Symptoms and developmental outcome in an international cohort of 63 patients
por: Pearson, Toni S., et al.
Publicado: (2020)

Clinical Features in Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Systematic Review
por: Rizzi, Susanna, et al.
Publicado: (2022)

Effects of levodopa/carbidopa intestinal gel versus oral levodopa/carbidopa on B vitamin levels and neuropathy
por: Loens, Sebastian, et al.
Publicado: (2017)

Parkinson’s disease: carbidopa, nausea, and dyskinesia
por: Hinz, Marty, et al.
Publicado: (2014)

Levodopa/carbidopa: Hallucinations: case report
Publicado: (2022)

Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis
por: Walker, Matthew D, et al.
Publicado: (2013)

Combination Treatment of Icariin and L-DOPA Against 6-OHDA-Lesioned Dopamine Neurotoxicity
por: Lu, Di-Sheng, et al.
Publicado: (2018)

Changes in Excitability Properties of Ventromedial Motor Thalamic Neurons in 6-OHDA Lesioned Mice
por: Bichler, Edyta K., et al.
Publicado: (2021)

Aromatic L-amino Acid Decarboxylase (AADC) deficiency: results from an Italian modified Delphi consensus
por: Fusco, Carlo, et al.
Publicado: (2021)

Effects of One-Day Application of Levodopa/Carbidopa/Entacapone versus Levodopa/Carbidopa/Opicapone in Parkinson’s Disease Patients
por: Müller, Thomas, et al.
Publicado: (2022)

A Discrete Choice Experiment to Derive Health Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency
por: Smith, Adam B, et al.
Publicado: (2021)

Effects of Cultured Adrenal Chromaffin Cell Implants on Hindlimb Reflexes of the 6-OHDA Lesioned Rat
por: Pulford, Bruce E., et al.
Publicado: (1994)

Corrigendum: Combination Treatment of Icariin and L-DOPA Against 6-OHDA-Lesioned Dopamine Neurotoxicity
por: Lu, Di-Sheng, et al.
Publicado: (2020)

Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Retraction]
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h7rbusvk7s7g6peta1k5io5klf